Overview of all submitted topics and lectures by national and international speakers
Congress Topics
Foreign Speakers:
Marwan El Ghoch
Why body comosition should be measured in people with obesity?
John Stevenson:
Hormone replacement therapy and coronary disease:
between a rock and a hard place? - Is there a place for hormone replacement therapy in
postmenopausal osteoporosis prevention?
bjbknk
Mark Brincat:
Musculoskeletal and connective tissue changes at the time of the
Menopause and their response to treatment - PCO in the over 40s: implicationsm diagnosis , investigation,
management.
Blazej Meczekalski:
Runners, athletes, dancers - Kisspeptin and neurokinin B potential therapeutic roles in
Gynecological endocrinology
Tamer Erel:
Menopause and the kidney health
Camil Castelo-Branco:
Menopause and sexual function: the perfect storm - POI
Attila Jakab:
Changing etiologies of POI and the importance of early diagnosis
Larisa Marchenkova:
Obesity and osteoporosis are a metabolic paradox or widespread
Comorbidity.
Saša Krunić:
Combatting hair thinning , hair loss in perimenppause: exploring the
hormonal transition and settings up the guidelines for successful management
Tomaso Simoncini:
The evolution of menopause and the menopausal care
Anne Beatrice Kinara
Shantha Kumari:
DHEERA – no to violence against women: role of obstetrics and
gynecology -Managing of postpartal haemorrhage
Max Brincat:
Endometriosis. Latest news
Anna Chapman:
Non invasive treating of skin in the menopause
Domestic Speakers:
Svetlana Vujović:
POI and pluriglandular autoimmune insufficiency
Marko Stojanović:
Primary and secondary prevention of pathological fractures – “For whom the bell tolls?”
Svetlana Dragojević Dikić:
POI, stress and reproduction
Olivera Ilić Stojanović:
Intra-articular therapy of osteoarthritis
Radomir Aničić:
Factors associated with anxiety and depression in women during infertility treatment
Mira Doknić:
Genetically caused hypogonadism in late adolescence
Sandra Pekić Đurđević:
Treatment of infertility in patients with hypothalamic hypogonadotropic hypogonadism
Sanja Medenica:
Achieving thyroid balance as a prerequisite for successful pregnancy
Svetlana Spremović Rađenović:
Why should genotype be part of PCOS diagnosis?
Milena Brkić:
PCOS in adolescence
Damir Franić:
Can TECAR radiofrequency become a new option in the treatment of overactive bladder and urge urinary incontinence?
Aleksandar Đogo:
Rejuvenation of the human organism after the age of 60
Dragana Miljić:
Primary hyperparathyroidism in menopause
Snežana Polovina:
Obesity therapy: prevention of complications
Mira Stojković:
Prevention of osteoporosis during TSH suppressive therapy in thyroid carcinoma: balancing oncological benefit and skeletal risk
Snežana Rakić:
Hormonal therapy of endometriosis: endocrine aspects of complication prevention
Marina Nikolić:
Hypercortisolemia and bone
Aleksandra Jotić:
Prevention of adverse pregnancy outcomes complicated by type 1 diabetes: use of automated insulin delivery systems
Ljiljana Lukić:
Effective and early intervention in prediabetes – prevention of complications and life extension
Gordana Milić:
Prevention and treatment of diabetic foot – contemporary modalities
Dragana Duišin:
Strategies for prevention of psychological complications within gender-affirming medical care
Edita Stokić:
Menopause and weight gain: myth or reality?
Sanja Ognjanović:
Infectious complications in Cushing syndrome
Slađana Mihajlović:
Use of lasers in menopause
Tanja Miličić:
Type 1 diabetes and cardiovascular risk: challenges in prevention and therapy
Biljana Beleslin:
TSH suppressive therapy: recommendations and possible complications
Marija Miletić:
Adaptation of muscle mass and strength in menopausal women
Snježana Popović Pejčić:
Cardiorenometabolic continuum in endocrinology throughout life: from early dysfunctional adiposity to cardiovascular outcomes
Milina Tančić Gajić:
PCOS and hyperandrogenism in reproductive age: diagnostic challenges and clinical dilemmas
Zorana Arizanović:
Candida and Karyneit – myth or reality
Veljko Pantović:
Influence of estrogen-progestagen therapy on testicular and prostate size in trans women
Natalija Pavlović:
Gonadal steroids – protectors of immunity
Anđela Bošković:
Menopausal hormone therapy vs. antiresorptive drugs in fracture prevention in menopausal women
Aleksandra Marković:
Woman and MASLD: where hormones, metabolism and risks meet
Zoran Gluvić:
Innovative biomarkers and therapy of MASLD
Ljiljana Marina:
Endocrinological framework of diminished ovarian reserve
Ivan Fistonić:
Femininity forever – sexuality forever
Branka Nikolić:
Epidemic of endometrial polyps / diagnostic and therapeutic solutions
Srđan Popović:
Sex and diabetes – what was diabetes again?
Mira Šumarac:
Metabolic transition in perimenopause. The role of GLP-1 receptor agonists in complication prevention and risk modification